Discontinued — last reported Q4 '20

Operating

Debt Issuance Cost Amortization

Insmed Debt Issuance Cost Amortization increased by 0.4% to $1.38M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 24.1%, from $1.82M to $1.38M. Over 4 years (FY 2021 to FY 2025), Debt Issuance Cost Amortization shows an upward trend with a 34.7% CAGR.

Analysis

StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2015
Last reportedQ4 2020

How to read this metric

An increase suggests higher historical debt issuance activity, while a decrease indicates maturing debt or lower financing costs.

Detailed definition

This represents the non-cash periodic allocation of costs incurred to issue debt, such as legal fees and underwriting co...

Peer comparison

Standard across capital-intensive industries; peers with higher leverage typically report higher amortization levels.

Metric ID: amortization_of_debt_issuance_costs

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$457.00K$541.00K$542.00K$822.00K$821.00K$822.00K$1.53M$1.72M$2.00M$1.84M$1.75M$1.85M$1.80M$1.49M$1.75M$1.82M$1.68M$1.34M$1.38M$1.38M
QoQ Change+18.4%+0.2%+51.7%-0.1%+0.1%+85.6%+13.0%+16.2%-8.2%-4.8%+5.7%-2.8%-17.5%+17.7%+4.2%-8.0%-19.9%+2.5%+0.4%
YoY Change+79.6%+51.9%+181.5%+109.7%+144.1%+123.8%+14.8%+7.4%-10.2%-19.3%-0.2%-1.6%-6.9%-9.6%-21.3%-24.1%
Range$457.00K$2.00M
CAGR+26.2%
Avg YoY Growth+38.7%
Median YoY Growth+3.6%
Current Streak2 quarters growth

Frequently Asked Questions

What is Insmed's debt issuance cost amortization?
Insmed (INSM) reported debt issuance cost amortization of $1.38M in Q1 2026.
How has Insmed's debt issuance cost amortization changed year-over-year?
Insmed's debt issuance cost amortization decreased by 24.1% year-over-year, from $1.82M to $1.38M.
What is the long-term trend for Insmed's debt issuance cost amortization?
Over 4 years (2021 to 2025), Insmed's debt issuance cost amortization has grown at a 34.7% compound annual growth rate (CAGR), from $1.89M to $6.22M.
What does debt issuance cost amortization mean?
The non-cash expense recognized over time for the costs associated with issuing debt.